CIPLA LTD. (INDIA)
Etoposide-etosid
“Etoposide” is the drug / molecule content in "Etosid". Etoposide is an inhibitor of the enzyme topoisomerase II. It is a derivative of podophyllotoxin (plant alkaloid) that inhibits DNA synthesis resulting in the arrest of the cell cycle.
Indication
Etoposide is used as a form of chemotherapy for malignancies such as Ewing's sarcoma, Lung cancer, Testicular cancer, Lymphoma, Non-Lymphocytic Leukemia, and Glioblastomamultiforme. It is also sometimes used in a conditioning regimen prior to a bone marrow or blood stem cell transplant.
Note
Precaution
- Etosid is a prescription drug and should be used under proper medical guidance and advice.
- Caution should be exercised in patients with history of kidney disease, bone marrow depression, infections, or blood disorder, any allergy, who are taking other medications, elderly, children, during pregnancy and breastfeeding.
Strength
50 mg & 100 mg
Packing
1 X 4 Capsule (50 mg) & Single dose vial (100 mg)
Storage
Store at room Temperature (25°C).